Skip to content

Identifying Skin Biopsy Sites

Pilot Study of Skin Biopsy Sites: A Consensus Approach Based on Patient and Physician Interviews

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01632644
Enrollment
59
Registered
2012-07-03
Start date
2012-07-31
Completion date
2013-05-31
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Identification of Skin Cancer Biopsy Sites

Brief summary

The primary objective of this study is to investigate the patient experience during skin biopsy.

Interventions

Each group will be surveyed and interviewed.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 and Over * The subjects are in good health. * The subjects have the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator. * Patients who have had one or multiple skin biopsies OR board-certified dermatologists.

Exclusion criteria

* Under 18 years of age. * Subjects who are unable to understand the protocol or give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Review of Physician and Patient ExperienceLast four weeks of studySubjects will answer a combination of: 1. Open-ended questions and 2. Questions asking for subject to rank possible responses

Secondary

MeasureTime frameDescription
Physician's Experience with Skin Biopsy SitesFirst four weeks of studyPhysicians will answer a combination of: 1. Open-ended questions, and 2. Questions asking for subject to rank possible responses
Patient's Experience with Skin Biopsy SitesFirst four weeks of studyPatients will answer a combination of: 1. Open-ended questions and 2. Questions asking for subject to rank possible responses

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026